Avalo Therapeutics (AVTX) Return on Capital Employed Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,288.00 |
| Dec 31, 2025 | 13,335.00 |
| Sep 30, 2025 | 7,425.00 |
| Jun 30, 2025 | 7,437.00 |
| Mar 31, 2025 | 13,539.00 |
| Dec 31, 2024 | -1,146.00 |
| Sep 30, 2024 | -11,809.00 |
| Jun 30, 2024 | -20,500.00 |
| Mar 31, 2024 | 11,826.00 |
| Dec 31, 2023 | -5,050.00 |
| Sep 30, 2023 | -4,207.00 |
| Jun 30, 2023 | -28,408.00 |
| Mar 31, 2023 | -25,025.00 |
| Dec 31, 2022 | -34,842.00 |
| Sep 30, 2022 | -42,142.00 |
| Jun 30, 2022 | 14,848.00 |
| Mar 31, 2022 | 53,988.00 |
| Dec 31, 2021 | 35,704.00 |
| Sep 30, 2021 | 33,286.00 |
| Jun 30, 2021 | -1,777.00 |
| Mar 31, 2021 | -16,220.00 |
| Dec 31, 2020 | -5,807.00 |